NCT07281807

Brief Summary

To compare the post operative mean pain scores by administering single-dose preoperative piroxicam and prednisolone in patients of irreversible pulpitis with symptomatic apical periodontitis.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for phase_4

Timeline
9mo left

Started Jan 2026

Shorter than P25 for phase_4

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
Jan 2026Jan 2027

First Submitted

Initial submission to the registry

December 2, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 15, 2025

Completed
17 days until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2027

Last Updated

December 15, 2025

Status Verified

December 1, 2025

Enrollment Period

12 months

First QC Date

December 2, 2025

Last Update Submit

December 2, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • pain after single visit root canal treatment

    pain score on visual analogue scale

    48 hours

Study Arms (2)

Group A: piroxicam

EXPERIMENTAL

Group A: patients will be given piroxicam 20mg as premedication

Drug: piroxicam 20mg

Group B: prednisolone

ACTIVE COMPARATOR

Group B: patients will be given prednisolone 20mg as premedication

Drug: Group B: patients will be given prednisolone 20mg as premedication

Interventions

Group B: patients will be given prednisolone 20mg as premedication

Group B: prednisolone

Group A: patients will be given piroxicam 20mg as premedication

Group A: piroxicam

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy patient ranging between 18-40 years
  • Having at least one premolar with diagnosis of symptomatic irreversible pulpitis according to history, examination and radiographs.
  • Teeth having mature apex confirmed by periapical radiographs.

You may not qualify if:

  • History of systemic disorders including HIV, Hepatitis
  • Pregnancy (As per Medical record/ Verbally)
  • Patient using medication such as analgesics or anti-inflammatory drugs
  • Patient allergic to lignocaine, piroxicam and prednisolone
  • Tooth not suitable for restoration
  • Periodontal probing depth ≥ 4mm
  • Retreatment cases
  • Patients having calcified canals assessed by radiographic findings

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Vatankhah M, Zargar N, Naseri M, Salem S, Baghban AA, Etemadi A, Dianat O. Analgesic Efficacy of Ibuprofen and Diclofenac Potassium on Postoperative Endodontic Pain in Maxillary and Mandibular First Molars with Irreversible Pulpitis: A Randomised Controlled Trial. Eur Endod J. 2023 Mar;8(2):133-139. doi: 10.14744/eej.2022.45238.

  • Benkhalil AM, Rmdan GA. Effect of Prednisolone Premedication on Postoperative Pain after Single Visit Endodontic Therapy: A Randomized Controlled Trial. Sch J App Med Sci. 2022;8:1219-26.

    RESULT

MeSH Terms

Interventions

PremedicationPiroxicam

Intervention Hierarchy (Ancestors)

Drug TherapyTherapeuticsThiazinesSulfur CompoundsOrganic ChemicalsHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Central Study Contacts

rana ahmad, B.D.S., F.C.P.S.

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

December 2, 2025

First Posted

December 15, 2025

Study Start

January 1, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

January 31, 2027

Last Updated

December 15, 2025

Record last verified: 2025-12